293780 — AptaBio Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for AptaBio Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS/A	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	22,911	16,995	51,885	31,496	17,079
Net Total Accounts Receivable
Net Total Receivables	479	3,047	2,659	1,435	3,195
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23,777	20,419	57,474	34,935	25,351
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,822	5,848	5,129	4,962	5,861
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	64,911	56,114	92,519	77,434	60,027
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	788	1,040	818	19,540	9,715
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	3,246	3,744	31,156	23,237	12,842
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	61,665	52,370	61,363	54,197	47,185
Total Liabilities & Shareholders' Equity	64,911	56,114	92,519	77,434	60,027
Total Common Shares Outstanding
Total Preferred Shares Outstanding